Skip Nav Destination
            
    
            
 
    
    
        
            
                
                
                    
                    
                        
                    
                
                
                    
                        
                        
                            
                        
                    
            
        
    
    
    
        
        
        
    
        
 
    
        
    
    
        
            
        
        
    
        
    
    
    
 
    
                
                    
            
    
        
    
    
                     
    
                     
    
                    
                    
                
            
    
    
    
        
        
     
    
                     
    
                    
                    
                
            
    
    
    
        
        
     
    
                    
        
                    
        
        Assessment of minimal residual disease using multiparametric flow cytometry in patients with AL amyloidosis
        
        
            
        
    
        
    
            
                
            
    
    
    
        
        
     
    
                    
        
        
                    
                
            
    
    
    
        
        
     
    
                    
        
                    
                
            
    
    
    
        
                    
                
            
    
    
    
        
                    
        
        Rituximab/bendamustine and rituximab/cytarabine induction therapy for transplant-eligible mantle cell lymphoma
        
        
            
        
    
        
                
            
    
    
    
        
        
                    
                
            
    
    
    
        
        
     
    
                    
        
                    
                
            
    
    
    
        
                    
        
        Clonal hematopoiesis predicts development of therapy-related myeloid neoplasms post–autologous stem cell transplantation
        
        
            
        
    
        
                
            
    
    
    
        
        
     
    
                     
    
                     
    
                     
    
 
    
            
    
        
    
         
 
    
    
        
    
            
    
        
    
    
    
        
    
    
    
            
    
                    
 
    
    
 
    
    
    
        
    
    
    
            
        
            
    
        
        
    
             
            
             
            
             
        
    
 
    
    
 
    
    
        
    
    
    
            
    
                    
 
    
    
 
    
    
 
    
    
    
    
        
    Issue Archive
March 10 2020
    
    
Table of Contents
BLOOD ADVANCES TALK
EXCEPTIONAL CASE REPORTS
STIMULUS REPORTS
Identification of germline variants in adults with hemophagocytic lymphohistiocytosis
            Peter G. Miller,Abhishek Niroula,John J. Ceremsak,Christopher J. Gibson,Martin S. Taylor,Sebastian Birndt,Florian Perner,Jon Arnason,Adam S. Sperling,Mridul Agrawal,Alison M. Schram,Sarah Nikiforow,German Pihan,Robert P. Hasserjian,Jon C. Aster,Paul La Rosée,Elizabeth A. Morgan,Nancy Berliner,Benjamin L. Ebert
            
        
    
            REVIEW ARTICLE
SYSTEMATIC REVIEW
Patient values and preferences regarding VTE disease: a systematic review to inform American Society of Hematology guidelines
            Itziar Etxeandia-Ikobaltzeta,Yuan Zhang,Francesca Brundisini,Ivan D. Florez,Wojtek Wiercioch,Robby Nieuwlaat,Housne Begum,Carlos A. Cuello,Yetiani Roldan,Ru Chen,Chengyi Ding,Rebecca L. Morgan,John J. Riva,Yuqing Zhang,Rana Charide,Arnav Agarwal,Sara Balduzzi,Gian Paolo Morgano,Juan José Yepes-Nuñez,Yasir Rehman,Ignacio Neumann,Nicole Schwab,Tejan Baldeh,Cody Braun,María Francisca Rodríguez,Holger J. Schünemann
            
        
    
            CLINICAL TRIALS AND OBSERVATIONS
        
        Assessment of minimal residual disease using multiparametric flow cytometry in patients with AL amyloidosis
        
        
            
        
                    
                        Clinical Trials & Observations
                    
        
            
    
        
    
            IMMUNOBIOLOGY AND IMMUNOTHERAPY
A novel C2 domain binding CD33xCD3 bispecific antibody with potent T-cell redirection activity against acute myeloid leukemia
            Priyanka Nair-Gupta,Michael Diem,Dara Reeves,Weirong Wang,Robert Schulingkamp,Katrin Sproesser,Bethany Mattson,Bradley Heidrich,Mark Mendonça,Jocelin Joseph,Jocelyn Sendecki,Brad Foulk,Gerald Chu,Damien Fink,Qun Jiao,Sheng-Jiun Wu,Kathryn Packman,Yusri Elsayed,Ricardo Attar,François Gaudet
            
        
    
            LYMPHOID NEOPLASIA
Copanlisib synergizes with conventional and targeted agents including venetoclax in B- and T-cell lymphoma models
            Chiara Tarantelli,Martin Lange,Eugenio Gaudio,Luciano Cascione,Filippo Spriano,Ivo Kwee,Alberto J. Arribas,Andrea Rinaldi,Thibaud Jourdan,Melanie Berthold,Andrea Sturz,Carolyn Sperl,Francesco Margheriti,Lorenzo Scalise,Giuseppe Gritti,Davide Rossi,Anastasios Stathis,Ningshu Liu,Emanuele Zucca,Oliver Politz,Francesco Bertoni
            
        
    
            Integrative analysis of the genomic and transcriptomic landscape of double-refractory multiple myeloma
            Bachisio Ziccheddu,Giulia Biancon,Filippo Bagnoli,Chiara De Philippis,Francesco Maura,Even H. Rustad,Matteo Dugo,Andrea Devecchi,Loris De Cecco,Marialuisa Sensi,Carolina Terragna,Marina Martello,Tina Bagratuni,Efstathios Kastritis,Meletios A. Dimopoulos,Michele Cavo,Cristiana Carniti,Vittorio Montefusco,Paolo Corradini,Niccolo Bolli
            
        
    
            
        
        Rituximab/bendamustine and rituximab/cytarabine induction therapy for transplant-eligible mantle cell lymphoma
        
        
            
        
                    
                        Clinical Trials & Observations
                    
        
            
    
        
            Reid W. Merryman,Natasha Edwin,Robert Redd,Jad Bsat,Matthew Chase,Ann LaCasce,Arnold Freedman,Caron Jacobson,David Fisher,Samuel Ng,Jennifer Crombie,Austin Kim,Oreofe Odejide,Matthew S. Davids,Jennifer R. Brown,Heather Jacene,Amanda Cashen,Nancy L. Bartlett,Neha Mehta-Shah,Armin Ghobadi,Brad Kahl,Robin Joyce,Philippe Armand,Eric Jacobsen
            
        
    
            The application of RNA sequencing for the diagnosis and genomic classification of pediatric acute lymphoblastic leukemia
            Lauren M. Brown,Andrew Lonsdale,Andrea Zhu,Nadia M. Davidson,Breon Schmidt,Anthony Hawkins,Elise Wallach,Michelle Martin,Francoise M. Mechinaud,Seong Lin Khaw,Ray C. Bartolo,Louise E. A. Ludlow,Jackie Challis,Ian Brooks,Vida Petrovic,Nicola C. Venn,Rosemary Sutton,Ian J. Majewski,Alicia Oshlack,Paul G. Ekert
            
        
    
            MYELOID NEOPLASIA
Molecular pathogenesis of progression to myeloid leukemia from TET-insufficient status
            Raksha Shrestha,Mamiko Sakata-Yanagimoto,Koichiro Maie,Motohiko Oshima,Masatomo Ishihara,Yasuhito Suehara,Kota Fukumoto,Yaeko Nakajima-Takagi,Hirotaka Matsui,Takayasu Kato,Hideharu Muto,Tatsuhiro Sakamoto,Manabu Kusakabe,Yasuhito Nannya,Hideki Makishima,Hiroo Ueno,Ryunosuke Saiki,Seishi Ogawa,Kenichi Chiba,Yuichi Shiraishi,Satoru Miyano,Enguerran Mouly,Olivier A. Bernard,Toshiya Inaba,Haruhiko Koseki,Atsushi Iwama,Shigeru Chiba
            
        
    
            
        
        Clonal hematopoiesis predicts development of therapy-related myeloid neoplasms post–autologous stem cell transplantation
        
        
            
        
                    
                        Clinical Trials & Observations
                    
        
            
    
        
            Johannes Frasez Soerensen,Anni Aggerholm,Gitte Birk Kerndrup,Marcus Celik Hansen,Ina Kathrine Lykke Ewald,Marie Bill,Lene Hyldahl Ebbesen,Carina Agerbo Rosenberg,Peter Hokland,Maja Ludvigsen,Anne Stidsholt Roug
            
        
    
            RED CELLS, IRON, AND ERYTHROPOIESIS
TRANSFUSION MEDICINE
ERRATUM
- 
        
            Cover Image
        
        Cover Image![issue cover]()  COVER FIGURE 
 Coculture of human megakaryocytic microparticles (huMkMPs) with murine hematopoietic stem and progenitor cells (muHSPCs) promotes murine megakaryopoiesis. muHSPCs were cocultured with huMkMPs without any thrombopoietin supplementation for 5 days. At day 5, cells were harvested, fixed, and stained for expression of von Willebrand factor (red), β-tubulin I (green), and the nucleus (4′,6-diamidino-2-phenylindole [DAPI]; blue). Cells were visualized via confocal and bright-field microscopies. An individual megakaryocyte is shown. Color was enhanced for better visualization. See the article by Escobar et al.
- PDF Icon Front MatterFront Matter
- PDF Icon Editorial BoardEditorial Board
Advertisement intended for health care professionals
Advertisement intended for health care professionals
 
                    












